Business / Finance

RSS

Roka Bioscience reports revenue of $1.5 million for third quarter 2015

Roka Bioscience, Inc., a molecular diagnostics company focused on providing advanced testing solutions for the detection of foodborne pathogens, today reported its financial results for the quarter and nine months ended September 30, 2015.

12 Nov 2015

Syneron Medical reports revenue of $62.1 million for third quarter 2015

Syneron Medical Ltd., a leading global aesthetic device company, today announced financial results for the three month period ended September 30, 2015.

11 Nov 2015

LEO Pharma enters into Asset Purchase Agreement to acquire Astellas’ global dermatology business

LEO Pharma A/S, a global healthcare company dedicated to helping people achieve healthy skin, and Japanese pharmaceutical company Astellas Pharma Inc. today announced that they have entered into an Asset Purchase Agreement under which Astellas will transfer its global dermatology business to LEO Pharma for € 675 million.

11 Nov 2015

Juniper Pharmaceuticals’ third quarter product revenues increase 22% to $7.2 million

Juniper Pharmaceuticals, Inc., a women's health therapeutics company, today announced financial results for the three months ended September 30, 2015.

11 Nov 2015

New Global Energy and International Sustainability Group agree to manufacture, distribute MoringaUP Protein Bars

New Global Energy, Inc., a public company focused on Aqua-Farming, Agriculture, and Health & Wellness, has signed a distribution agreement with International Sustainability Group to manufacture and distribute MoringaUP Protein Bars based on ISG's popular AlgaeUp bars.

10 Nov 2015

SKYGEN USA announces launch of Hylis Pharmacy Solutions

Citing a need to bring skyrocketing pharmacy costs under control, SKYGEN USA, the umbrella brand for a distinguished family of benefit management companies and technology solutions for health payers and healthcare organizations, today announced the launch of Hylis Pharmacy Solutions.

10 Nov 2015

Boston Children's and Rock Health team up to accelerate development of pediatric health technologies

Boston Children's Hospital and digital health venture fund Rock Health today announced a strategic partnership aimed at accelerating the development of pediatric health technologies. Detailed today during Boston Children's Hospital's Global Pediatric Innovation Summit + Awards (#PedInno15), the partnership will foster the development of digital tools and devices to improve pediatric care.

10 Nov 2015

Boston Scientific signs definitive agreement to acquire CeloNova's interventional radiology business

Boston Scientific has entered into a definitive agreement to acquire the interventional radiology portfolio of CeloNova Biosciences, a San Antonio-based developer of endovascular and interventional cardiology technologies.

10 Nov 2015

Astellas enters into definitive agreement to acquire Ocata

Astellas Pharma Inc. and Ocata Therapeutics, Inc., a biotechnology company focused on the research and development of new therapies in the field of regenerative medicine, primarily cell therapy addressing unmet medical needs in ophthalmology patients, announced today that they have entered into a definitive agreement.

10 Nov 2015

Nightstar announces $35 million Series B financing round

NightstaRx Ltd, a biopharmaceutical company specialising in developing gene therapies for inherited retinal dystrophies, announces a $35 million Series B financing round. The round was led by New Enterprise Associates, one of the world's leading venture capital firms.

9 Nov 2015

Hill-Rom Holdings' fourth-quarter revenue increases 20% to $574 million

Hill-Rom Holdings, Inc. announced financial results for its fourth quarter ended September 30, 2015, and its fiscal year 2016 financial outlook. Adjusted earnings per diluted share of $0.89 increased 20 percent from $0.74 in the prior year.

5 Nov 2015

Linkam stages in use in the Wolfson Bioimaging Facility at the University of Bristol as part of the endocytic sorting research of Dr Paul Verkade

Market leaders in temperature controlled microscopy, Linkam Scientific Instruments report on the use of their temperature controlled stages applied to CLEM and fluorescence microscopy to assist in endocytic sorting in the School of Biochemistry at the University of Bristol.

From Linkam Scientific Instruments 4 Nov 2015

Johnson & Johnson signs definitive agreement to purchase Novira Therapeutics

Johnson & Johnson today announced a definitive agreement to acquire Novira Therapeutics, Inc., a privately held, clinical-stage biopharmaceutical company developing novel therapies for curative treatment of chronic hepatitis B virus (HBV) infection.

4 Nov 2015

BD reports quarterly adjusted revenues of $3.067 billion for fourth fiscal quarter 2015

BD (Becton, Dickinson and Company), a leading global medical technology company, today reported quarterly adjusted revenues of $3.067 billion for the fourth fiscal quarter ended September 30, 2015, an increase of 39.3 percent over the prior-year period as reported, or 49.1 percent on a currency-neutral basis.

4 Nov 2015

Allergan signs licensing agreement with Mimetogen to develop, commercialize tavilermide for treatment of dry eye disease

Allergan plc, a leading global pharmaceutical company, today announced that its wholly owned subsidiary has entered into an exclusive licensing agreement with Mimetogen Pharmaceuticals, a clinical stage biotechnology company, to develop and commercialize tavilermide (MIM-D3), a topical formulation of a novel small molecule TrkA agonist for the treatment of dry eye disease.

4 Nov 2015

Henry Schein's net sales increase 2.4% to $2.7 billion in third quarter 2015

Henry Schein, Inc., the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners, today reported record third quarter financial results.

4 Nov 2015

U.S. FTC clears Mylan's proposed transaction to acquire Perrigo

Mylan N.V. today announced the U.S. Federal Trade Commission has cleared the company's proposed transaction to acquire Perrigo Company plc subject to Mylan's divestiture of certain products following the consummation of the offer.

4 Nov 2015

OncoSec signs definitive agreements to purchase $7.5 million of securities in registered direct offering

OncoSec Medical Incorporated, a company developing DNA-based intratumoral cancer immunotherapies, announced today that it has entered into definitive agreements with institutional investors to purchase approximately $7.5 million of securities in a registered direct offering.

4 Nov 2015

‘Zero pressure’ mattress solutions to be showcased at MEDICA 2015

‘Stop the Pressure’ is the message from pressure ulcer specialist Rober, who is showcasing their wide range of innovative mattresses in support of Worldwide STOP Pressure Ulcer Day at MEDICA 2015, the world’s largest healthcare technology exhibition.

4 Nov 2015

Surgical startup seeks funding to build virtual reality training library

Medical Realities, a pioneering medical training startup, today announced that it is raising £400,000 in new investment to improve surgical education by creating a series of virtual and augmented reality training tutorials.

4 Nov 2015

Business / Finance

Roka Bioscience reports revenue of $1.5 million for third quarter 2015

Syneron Medical reports revenue of $62.1 million for third quarter 2015

LEO Pharma enters into Asset Purchase Agreement to acquire Astellas’ global dermatology business

Juniper Pharmaceuticals’ third quarter product revenues increase 22% to $7.2 million

New Global Energy and International Sustainability Group agree to manufacture, distribute MoringaUP Protein Bars

SKYGEN USA announces launch of Hylis Pharmacy Solutions

Boston Children's and Rock Health team up to accelerate development of pediatric health technologies

Boston Scientific signs definitive agreement to acquire CeloNova's interventional radiology business

Astellas enters into definitive agreement to acquire Ocata

Nightstar announces $35 million Series B financing round

Hill-Rom Holdings' fourth-quarter revenue increases 20% to $574 million

Linkam stages in use in the Wolfson Bioimaging Facility at the University of Bristol as part of the endocytic sorting research of Dr Paul Verkade

Johnson & Johnson signs definitive agreement to purchase Novira Therapeutics

BD reports quarterly adjusted revenues of $3.067 billion for fourth fiscal quarter 2015

Allergan signs licensing agreement with Mimetogen to develop, commercialize tavilermide for treatment of dry eye disease

Henry Schein's net sales increase 2.4% to $2.7 billion in third quarter 2015

U.S. FTC clears Mylan's proposed transaction to acquire Perrigo

OncoSec signs definitive agreements to purchase $7.5 million of securities in registered direct offering

‘Zero pressure’ mattress solutions to be showcased at MEDICA 2015

Surgical startup seeks funding to build virtual reality training library

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Latest News